8 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
EMPA-REG OUTCOME - Empagliflozin ... DAPA-HF - Dapagliflozin ... EMPEROR-REDUCED - Empagliflozin ... SGLT2 #inhibitors #EBM ... #trial #visualabstract
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

CONCLUSIONS:
Among patients with heart failure and a
Dapagliflozin in ... those who received dapagliflozin ... or absence of diabetes ... #hfref #chf #visualabstract ... #ebm
Diabetic Nephropathy - Timeline of Important Trials

Dr. Lovy Gaur https://twitter.com/drlovygaur

#Diabetic #Nephropathy #EBM #VisualAbstract #Trials #Nephrology #Timeline
Diabetic Nephropathy ... drlovygaur #Diabetic ... #Nephropathy #EBM ... #VisualAbstract
The Evidence for Aspirin - Visual Abstract

Three new aspirin trials in three different populations: 
 -
bleeding ASCEND - Diabetes ... mortality #Aspirin #VisualAbstract ... ASPREE #Management #EBM
Summary and links to five landmark trials of intensive control vs standard therapy in DM2:

 UKPDS
pubmed/18539917 #EBM ... #VisualAbstract ... #PrimaryCare #Diabetes
NICE-SUGAR - Intensive versus Conventional Glucose Control in Critically Ill Patients
N Engl J Med 2009; 360:1283-1297
Endocrinology #VisualAbstract ... #Diabetes #EBM
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
inhibitors that modulate ... treatment of type II diabetes ... (Farxiga®) and empagliflozin ... canagliflozin, #dapagliflozin ... , #empagliflozin
Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis - Kupperman et al. NEJM 2018

https://www.nejm.org/doi/full/10.1056/NEJMoa1716816
Study
for Pediatric Diabetic ... TessaRDavis #EBM ... #VisualAbstract